-+ 0.00%
-+ 0.00%
-+ 0.00%
AstraZeneca will launch Zefgrovy in the US in the fourth quarter of 2026 to treat non-small cell lung cancer.
Share
Listen to the news
AstraZeneca will launch Zefgrovy in the US in the fourth quarter of 2026 to treat non-small cell lung cancer.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending